- Home
- FOLD vs DRVN Comparison
FOLD vs DRVN Comparison
Compare FOLD & DRVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FOLD
- DRVN
- Stock Information
- Founded
- FOLD 2002
- DRVN 1972
- Country
- FOLD United States
- DRVN United States
- Employees
- FOLD N/A
- DRVN N/A
- Industry
- FOLD Biotechnology: Pharmaceutical Preparations
- DRVN Automotive Aftermarket
- Sector
- FOLD Health Care
- DRVN Consumer Discretionary
- Exchange
- FOLD Nasdaq
- DRVN Nasdaq
- Market Cap
- FOLD 2.9B
- DRVN 2.9B
- IPO Year
- FOLD 2007
- DRVN 2021
- Fundamental
- Price
- FOLD $6.12
- DRVN $17.73
- Analyst Decision
- FOLD Buy
- DRVN Buy
- Analyst Count
- FOLD 10
- DRVN 10
- Target Price
- FOLD $16.22
- DRVN $20.10
- AVG Volume (30 Days)
- FOLD 5.5M
- DRVN 642.2K
- Earning Date
- FOLD 08-07-2025
- DRVN 07-31-2025
- Dividend Yield
- FOLD N/A
- DRVN N/A
- EPS Growth
- FOLD N/A
- DRVN N/A
- EPS
- FOLD N/A
- DRVN N/A
- Revenue
- FOLD $543,141,000.00
- DRVN $2,373,759,000.00
- Revenue This Year
- FOLD $19.87
- DRVN N/A
- Revenue Next Year
- FOLD $23.15
- DRVN $8.10
- P/E Ratio
- FOLD N/A
- DRVN N/A
- Revenue Growth
- FOLD 28.25
- DRVN 6.75
- 52 Week Low
- FOLD $5.51
- DRVN $12.66
- 52 Week High
- FOLD $12.65
- DRVN $18.72
- Technical
- Relative Strength Index (RSI)
- FOLD 51.42
- DRVN 52.17
- Support Level
- FOLD $5.66
- DRVN $17.21
- Resistance Level
- FOLD $6.45
- DRVN $18.23
- Average True Range (ATR)
- FOLD 0.21
- DRVN 0.55
- MACD
- FOLD 0.07
- DRVN 0.03
- Stochastic Oscillator
- FOLD 64.89
- DRVN 67.27
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.
About DRVN Driven Brands Holdings Inc.
Driven Brands Holdings Inc is an automotive services company in North America. Its platform provides high-quality services to an extensive range of retail and commercial customers. The company provides an extensive range of core consumer and commercial automotive needs, including paint, collision, glass, and repair services, as well as a variety of high-frequency services, such as oil changes and car washes. The company segments include: Maintenance, Car Wash, Paint, Collision & Glass, and Platform Services. It derives maximum revenue from Maintenance Segment. Geographically, the company operates into United States, Canada and Rest of the World.